Hydroxymethylglutaryl-CoA Reductase Inhibitors [Pharmacological Action]
Tree Number(s): D019161
MeSH Unique ID: D019161
- mevastatin (Supplementary Concept)
- phosphoadenosine diphosphoribose (Supplementary Concept)
- dihydromevinolin (Supplementary Concept)
- dihydrocompactin (Supplementary Concept)
- 6-hydroxyisocompactin (Supplementary Concept)
- fermodulin (Supplementary Concept)
- 6-(2-(2,4-dichloro-6-hydroxyphenyl)ethyl)-3,4,5,6-tetrahydro-4-hydroxy-2H-pyran-2-one (Supplementary Concept)
- methoxypolyethoxylated cholesterol (Supplementary Concept)
- SRI 62320 (Supplementary Concept)
- 7-(2'-((2''-methyl-1''-oxobutoxy)methyl)-1'-cyclohexyl)-3-hydroxy-5-oxoheptanoic acid (Supplementary Concept)
- lanost-8-en-3-ol-24-one (Supplementary Concept)
- cholest-8-ene-3,15-diol (Supplementary Concept)
- HR 780 (Supplementary Concept)
- L 645164 (Supplementary Concept)
- L 157012 (Supplementary Concept)
- L 647318 (Supplementary Concept)
- BMY 21950 (Supplementary Concept)
- SQ 33600 (Supplementary Concept)
- L 669262 (Supplementary Concept)
- 6-(2-(8-((4-fluorobenzyl)oxy)-1,2,6,7,8,8a-hexahydro-2,6-dimethyl-1-naphthyl)ethyl)-4-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-one (Supplementary Concept)
- pannorin (Supplementary Concept)
- 3,25-dihydroxycholest-8(14)-en-15-one (Supplementary Concept)
- 3-hydroxy-24-dimethylaminochol-8(14)-en-15-one (Supplementary Concept)
- RP 61969 (Supplementary Concept)
- 2,6,7-trideoxy-7-C-(2,4-dichlorophenyl)heptonic acid (Supplementary Concept)
- 6-(2,4-dichlorophenyl)-2,3,4-trihydroxyhexanesulfonic acid (Supplementary Concept)
- 7-(2,4-dichlorophenyl)-3-hydroxy-5-heptanolide (Supplementary Concept)
- 6-(2,4-dichlorophenyl)-2,4-dihydroxyhexane-1-sulfonic acid (Supplementary Concept)
- 6-(2,4-dichlorophenyl)-erythro-2,4-dihydroxyhexylphosphonic acid (Supplementary Concept)
- 3-hydroxycholest-8(14),24-dien-15-one (Supplementary Concept)
- 3,24-dihydroxycholest-8(14)-en-15-one (Supplementary Concept)
- GR 92549 (Supplementary Concept)
- crilvastatin (Supplementary Concept)
- chrysosporin (Supplementary Concept)
- PD 123244-15 (Supplementary Concept)
- 3-hydroxy-25,26,26,26,27,27,27-heptafluoro-5-cholest-8(14)-en-15-one (Supplementary Concept)
- 7-(3-bromo-4,5-bis(4-fluorophenyl)-2-(1-methylethyl)-1H-pyrrol-1-yl)-3,5-dihydroxy-6-heptenoic acid methyl ester (Supplementary Concept)
- 7-(7-((1,1'-biphenyl-4-yl)methyl)-2-(4-fluorophenyl)-4,5,6,7-tetrahydro-2H-indazol-3-yl)-3,5-dihydroxy-6-heptenoic acid (Supplementary Concept)
- 7-(3-hydroxy-2-methyl-1,2,3,5,6,7,8,8a-octahydro-1-naphtalenyl)-3,5-dihydroxyheptanoic acid (Supplementary Concept)
- cerivastatin (Supplementary Concept)
- GR 95030X (Supplementary Concept)
- 2-(2-(3-hydroxy-12-(2-methyl-1-oxobutoxy)-5-androstan-17-yl)ethyl)tetrahydro-4-hydroxy-2H-pyran-6-one (Supplementary Concept)
- pitavastatin (Supplementary Concept)
- red yeast rice (Supplementary Concept)
- amlodipine, atorvastatin drug combination (Supplementary Concept)
- 3,4-dihydroxyphenylpropionylleucinamide (Supplementary Concept)
- Lovastatin (MeSH Term)
- Meglutol (MeSH Term)
- Pravastatin (MeSH Term)
- Simvastatin (MeSH Term)
- Rosuvastatin Calcium (MeSH Term)
- Atorvastatin (MeSH Term)